Rocket Pharmaceuticals Is Maintained at Buy by Chardan Capital
Ratings actions GMT) Rocket Pharmaceuticals Price Target Maintained With a $11.00/Share by Chardan CapitalRatings actions
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.